QUARTERLY REPORT

Q3 2023 — Form 10-Q

Q3 2023PDF · 33 pages400 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended September 30, 2023
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware 	75-0289970
(State of Incorporation) 	(I.R.S. Employer Identification No.)
12500 TI Boulevard, Dallas, Texas 	75243
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code 214-479-3773
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, par value $1.00 	TXN 	The Nasdaq Global Select Market
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was
required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
908,204,093
Number of shares of Registrant’s common stock outstanding as of
October 17, 2023

-- 1 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
ITEM 1. Financial statements
For Three Months Ended 	For Nine Months Ended
Consolidated Statements of Income 	September 30, 	September 30,
(In millions, except per-share amounts) 	2023 	2022 	2023 	2022
Revenue 	$ 	4,532 $ 	5,241 $ 	13,442 $ 	15,358
Cost of revenue (COR) 	1,717 	1,624 	4,854 	4,674
Gross profit 	2,815 	3,617 	8,588 	10,684
Research and development (R&D) 	471 	431 	1,403 	1,236
Selling, general and administrative (SG&A) 	452 	431 	1,387 	1,275
Restructuring charges/other 	— 	77 	— 	209
Operating profit 	1,892 	2,678 	5,798 	7,964
Other income (expense), net (OI&E) 	128 	33 	327 	55
Interest and debt expense 	98 	53 	255 	154
Income before income taxes 	1,922 	2,658 	5,870 	7,865
Provision for income taxes 	213 	363 	731 	1,078
Net income 	$ 	1,709 $ 	2,295 $ 	5,139 $ 	6,787
Earnings per common share (EPS):
Basic 	$ 	1.87 $ 	2.50 $ 	5.63 $ 	7.35
Diluted 	$ 	1.85 $ 	2.47 $ 	5.58 $ 	7.27
Average shares outstanding:
Basic 	908 	913 	908 	919
Diluted 	916 	923 	916 	929
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is
calculated using the following:
Net income 	$ 	1,709 $ 	2,295 $ 	5,139 $ 	6,787
Income allocated to RSUs 	(10) 	(11) 	(26) 	(30)
Income allocated to common stock for diluted EPS 	$ 	1,699 $ 	2,284 $ 	5,113 $ 	6,757
See accompanying notes.
2

-- 2 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Three Months Ended 	For Nine Months Ended
Consolidated Statements of Comprehensive Income 	September 30, 	September 30,
(In millions) 	2023 	2022 	2023 	2022
Net income 	$ 	1,709 $ 	2,295 $ 	5,139 $ 	6,787
Other comprehensive income (loss)
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($3) and ($4); ($4) and $2 	6 	11 	6 	(23)
Recognized within net income, net of tax effect of ($1) and ($4); ($3)
and ($9) 	3 	15 	9 	33
Prior service cost (credit) of defined benefit plans:
Adjustments, net of tax effect of $0 and $0; $0 and $0 	— 	1 	— 	1
Recognized within net income, net of tax effect of $0 and $0; $0 and $0 	1 	(1) 	1 	(1)
Derivative instruments:
Change in fair value, net of tax effect of $0 and $0; $0 and $0 	— 	1 	1 	1
Available-for-sale investments:
Unrealized gains (losses), net of tax effect of $0 and $0; $0 and $2 	1 	(1) 	2 	(8)
Other comprehensive income (loss), net of taxes 	11 	26 	19 	3
Total comprehensive income 	$ 	1,720 $ 	2,321 $ 	5,158 $ 	6,790
See accompanying notes.
3

-- 3 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
September 30, 	December 31,
Consolidated Balance Sheets 	2023 	2022
(In millions, except par value)
Assets
Current assets:
Cash and cash equivalents 	$ 	2,566 $ 	3,050
Short-term investments 	6,382 	6,017
Accounts receivable, net of allowances of ($15) and ($13) 	1,976 	1,895
Raw materials 	401 	353
Work in process 	2,147 	1,546
Finished goods 	1,360 	858
Inventories 	3,908 	2,757
Prepaid expenses and other current assets 	265 	302
Total current assets 	15,097 	14,021
Property, plant and equipment at cost 	12,528 	9,950
Accumulated depreciation 	(3,208) 	(3,074)
Property, plant and equipment 	9,320 	6,876
Goodwill 	4,362 	4,362
Deferred tax assets 	632 	473
Capitalized software licenses 	138 	152
Overfunded retirement plans 	166 	188
Other long-term assets 	1,923 	1,135
Total assets 	$ 	31,638 $ 	27,207
Liabilities and stockholders’ equity
Current liabilities:
Current portion of long-term debt 	$ 	300 $ 	500
Accounts payable 	713 	851
Accrued compensation 	707 	799
Income taxes payable 	108 	189
Accrued expenses and other liabilities 	824 	646
Total current liabilities 	2,652 	2,985
Long-term debt 	10,922 	8,235
Underfunded retirement plans 	141 	118
Deferred tax liabilities 	66 	66
Other long-term liabilities 	1,226 	1,226
Total liabilities 	15,007 	12,630
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued 	— 	—
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741 	1,741 	1,741
Paid-in capital 	3,280 	2,951
Retained earnings 	52,098 	50,353
Treasury common stock at cost
Shares: September 30, 2023 – 833; December 31, 2022 – 835 	(40,253) 	(40,214)
Accumulated other comprehensive income (loss), net of taxes (AOCI) 	(235) 	(254)
Total stockholders’ equity 	16,631 	14,577
Total liabilities and stockholders’ equity 	$ 	31,638 $ 	27,207
See accompanying notes.
4

-- 4 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Nine Months Ended
Consolidated Statements of Cash Flows 	September 30,
(In millions) 	2023 	2022
Cash flows from operating activities
Net income 	$ 	5,139 $ 	6,787
Adjustments to net income:
Depreciation 	853 	676
Amortization of capitalized software 	48 	40
Stock compensation 	294 	227
Gains on sales of assets 	(1) 	(3)
Deferred taxes 	(159) 	(18)
Increase (decrease) from changes in:
Accounts receivable 	(81) 	(339)
Inventories 	(1,151) 	(494)
Prepaid expenses and other current assets 	38 	45
Accounts payable and accrued expenses 	(23) 	72
Accrued compensation 	(97) 	(114)
Income taxes payable 	(65) 	26
Changes in funded status of retirement plans 	49 	126
Other 	(348) 	(353)
Cash flows from operating activities 	4,496 	6,678
Cash flows from investing activities
Capital expenditures 	(3,923) 	(1,830)
Proceeds from asset sales 	3 	3
Purchases of short-term investments 	(10,140) 	(10,795)
Proceeds from short-term investments 	9,976 	10,007
Other 	33 	59
Cash flows from investing activities 	(4,051) 	(2,556)
Cash flows from financing activities
Proceeds from issuance of long-term debt 	3,000 	695
Repayment of debt 	(500) 	(500)
Dividends paid 	(3,376) 	(3,174)
Stock repurchases 	(228) 	(2,767)
Proceeds from common stock transactions 	218 	191
Other 	(43) 	(29)
Cash flows from financing activities 	(929) 	(5,584)
Net change in cash and cash equivalents 	(484) 	(1,462)
Cash and cash equivalents at beginning of period 	3,050 	4,631
Cash and cash equivalents at end of period 	$ 	2,566 $ 	3,169
See accompanying notes.
5

-- 5 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Notes to financial statements
1. Description of business, including segment and geographic area information
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two
reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis
of similar design and development requirements, product characteristics, manufacturing processes and distribution channels. Our segments
also reflect how management allocates resources and measures results.
• Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying
them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded
processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing,
discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog
segment consists of two major product lines: Power and Signal Chain.
• Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific
tasks and can be optimized for various combinations of performance, power and cost, depending on the application.
We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative
thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP products,
calculators and custom ASIC products.
Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating
segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit
basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not
provided.
Segment information
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2023 	2022 	2023 	2022
Revenue:
Analog 	$ 	3,353 $ 	3,993 $ 	9,920 $ 	11,801
Embedded Processing 	890 	821 	2,616 	2,424
Other 	289 	427 	906 	1,133
Total revenue 	$ 	4,532 $ 	5,241 $ 	13,442 $ 	15,358
Operating profit:
Analog 	$ 	1,504 $ 	2,185 $ 	4,541 $ 	6,561
Embedded Processing 	258 	321 	813 	960
Other (a) 	130 	172 	444 	443
Total operating profit 	$ 	1,892 $ 	2,678 $ 	5,798 $ 	7,964
(a) Includes restructuring charges/other
®
6

-- 6 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Geographic area information
The following geographic area information is based on product shipment destination, which does not reflect end demand by geography.
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2023 	2022 	2023 	2022
Revenue:
United States 	$ 	630 	14 % $ 	694 	13 % $ 1,900 	14 % $ 1,765 	11 %
China (a) 	1,880 	41 	2,441 	47 	5,531 	41 	7,740 	50
Rest of Asia 	571 	13 	694 	13 	1,654 	12 	1,993 	13
Europe, Middle East and Africa 	952 	21 	942 	18 	2,894 	22 	2,578 	17
Japan 	338 	7 	310 	6 	976 	7 	849 	6
Rest of world 	161 	4 	160 	3 	487 	4 	433 	3
Total revenue 	$ 4,532 	100 % $ 5,241 	100 % $ 13,442 	100 % $ 15,358 	100 %
(a) Revenue from products shipped into China includes shipments to customers that manufacture in China and then export end products to
their customers around the world, as well as distributors that transship inventory through China to service other countries.
The following additional geographic information includes our estimate for revenue based on the location of our end customers’ headquarters,
providing a better representation of the geographic profile for where critical decisions are made.
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2023 	2022 	2023 	2022
Revenue:
United States 	$ 1,541 	34 % $ 1,782 	34 % $ 4,391 	33 % $ 5,058 	33 %
China 	813 	18 	1,143 	22 	2,561 	19 	3,758 	24
Rest of Asia 	434 	10 	534 	10 	1,263 	10 	1,643 	11
Europe, Middle East and Africa (a) 	1,193 	26 	1,281 	24 	3,657 	27 	3,480 	23
Japan 	455 	10 	446 	9 	1,373 	10 	1,252 	8
Rest of world 	96 	2 	55 	1 	197 	1 	167 	1
Total revenue 	$ 4,532 	100 % $ 5,241 	100 % $ 13,442 	100 % $ 15,358 	100 %
(a) Revenue from end customers headquartered in Germany was 13% and 11% in the third quarters of 2023 and 2022, respectively, and
13% and 10% in the first nine months of 2023 and 2022, respectively.
7

-- 7 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
2. Basis of presentation and significant accounting policies and practices
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December
31, 2022. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2023 and
2022, and the Consolidated Balance Sheet as of September 30, 2023, are not audited but reflect all adjustments that are of a normal
recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally
included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and
Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by
GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and
notes included in our annual report on Form 10-K for the year ended December 31, 2022. The results for the three- and nine-month periods
are not necessarily indicative of a full year’s results.
Significant accounting policies and practices
Earnings per share (EPS)
We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing
non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded
from the calculation of income allocated to common stock.
8

-- 8 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Computation and reconciliation of earnings per common share are as follows:
For Three Months Ended September 30,
2023 	2022
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	1,709 	$ 	2,295
Income allocated to RSUs 	(9) 	(11)
Income allocated to common stock 	$ 	1,700 	908 $ 	1.87 $ 	2,284 	913 $ 	2.50
Dilutive effect of stock compensation plans 	8 	10
Diluted EPS:
Net income 	$ 	1,709 	$ 	2,295
Income allocated to RSUs 	(10) 	(11)
Income allocated to common stock 	$ 	1,699 	916 $ 	1.85 $ 	2,284 	923 $ 	2.47
For Nine Months Ended September 30,
2023 	2022
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	5,139 	$ 	6,787
Income allocated to RSUs 	(27) 	(30)
Income allocated to common stock 	$ 	5,112 	908 $ 	5.63 $ 	6,757 	919 $ 	7.35
Dilutive effect of stock compensation plans 	8 	10
Diluted EPS:
Net income 	$ 	5,139 	$ 	6,787
Income allocated to RSUs 	(26) 	(30)
Income allocated to common stock 	$ 	5,113 	916 $ 	5.58 $ 	6,757 	929 $ 	7.27
Potentially dilutive securities representing 9 million and 6 million shares of common stock that were outstanding during the third quarters of
2023 and 2022, respectively, and 9 million and 5 million shares outstanding during the first nine months of 2023 and 2022, respectively, were
excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-
dilutive.
Derivatives and hedging
We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign
currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have
on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency
exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.
We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total
return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the
swaps and the related deferred compensation liabilities in SG&A.
In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are
recognized in AOCI and amortized over the life of the related debt.
The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes.
9

-- 9 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Fair values of financial instruments
The fair values of our derivative financial instruments were not material as of September 30, 2023. Our investments in cash equivalents,
short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The
carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value
due to the short maturity of such instruments. As of September 30, 2023, the carrying value of long-term debt, including the current portion,
was $11.22 billion, and the estimated fair value was $9.82 billion. The estimated fair value is measured using broker-dealer quotes, which are
Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
3. Income taxes
Provision for income taxes is based on the following:
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2023 	2022 	2023 	2022
Taxes calculated using the estimated annual effective tax rate 	$ 	229 	$ 	391 	$ 	794 	$ 	1,147
Discrete tax items 	(16) 	(28) 	(63) 	(69)
Provision for income taxes 	$ 	213 	$ 	363 	$ 	731 	$ 	1,078
Effective tax rate 	11 % 	14 % 	12 % 	14 %
The effective tax rate differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.
4. Valuation of debt and equity investments and certain liabilities
Investments measured at fair value
Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes.
We classify all debt investments as available-for-sale. See Fair-value considerations. Unrealized gains and losses are recorded as an
increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for
credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.
Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred
compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.
Other investments
Our other investments include equity-method investments and non-marketable investments, which are not measured at fair value. These
investments consist of interests in venture capital funds and other non-marketable securities. Gains and losses from equity-method
investments are recognized in OI&E based on our ownership share of the investee’s financial results.
Non-marketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-
marketable investments are recognized in OI&E.
10

-- 10 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details of our investments are as follows:
September 30, 2023 	December 31, 2022
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Measured at fair value:
Money market funds 	$ 	1,141 $ 	— $ 	— $ 	1,238 $ 	— $ 	—
Corporate obligations 	280 	1,519 	— 	276 	1,535 	—
U.S. government and agency securities 	398 	4,467 	— 	680 	4,234 	—
Non-U.S. government and agency
securities 	100 	396 	— 	149 	248 	—
Mutual funds 	— 	— 	11 	— 	— 	11
Total 	1,919 	6,382 	11 	2,343 	6,017 	11
Other measurement basis:
Equity-method investments 	— 	— 	16 	— 	— 	18
Non-marketable investments 	— 	— 	5 	— 	— 	5
Cash on hand 	647 	— 	— 	707 	— 	—
Total 	$ 	2,566 $ 	6,382 $ 	32 $ 	3,050 $ 	6,017 $ 	34
As of September 30, 2023, and December 31, 2022, unrealized gains and losses associated with our debt investments were not material.
We did not recognize any credit losses related to debt investments for the first nine months of 2023 and 2022.
The following table presents the aggregate maturities of our available-for-sale debt investments as of September 30, 2023:
Fair Value
One year or less 	$ 	6,775
One to two years 	385
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.89 billion and $3.03 billion for the third
quarters of 2023 and 2022, respectively, and $9.98 billion and $10.01 billion for the first nine months of 2023 and 2022, respectively. Gross
realized gains and losses from these sales were not material.
Fair-value considerations
We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the measurement date.
The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.
• Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.
11

-- 11 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
• Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation
with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not
active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require
significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by
readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for
reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in
active markets.
• Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management
judgment. These values are generally determined using pricing models that utilize management estimates of market participant
assumptions. As of September 30, 2023, and December 31, 2022, we had no Level 3 assets or liabilities.
The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on
hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.
September 30, 2023 	December 31, 2022
Level 1 	Level 2 	Total 	Level 1 	Level 2 	Total
Assets:
Money market funds 	$ 	1,141 $ 	— $ 	1,141 $ 	1,238 $ 	— $ 	1,238
Corporate obligations 	— 	1,799 	1,799 	— 	1,811 	1,811
U.S. government and agency securities 	4,161 	704 	4,865 	4,914 	— 	4,914
Non-U.S. government and agency securities 	— 	496 	496 	— 	397 	397
Mutual funds 	11 	— 	11 	11 	— 	11
Total assets 	$ 	5,313 $ 	2,999 $ 	8,312 $ 	6,163 $ 	2,208 $ 	8,371
Liabilities:
Deferred compensation 	$ 	352 $ 	— $ 	352 $ 	326 $ 	— $ 	326
Total liabilities 	$ 	352 $ 	— $ 	352 $ 	326 $ 	— $ 	326
12

-- 12 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
5. Postretirement benefit plans
Expenses related to defined benefit and retiree health care benefit plans are as follows:
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Three Months Ended September 30, 	2023 	2022 	2023 	2022 	2023 	2022
Service cost 	$ 	2 $ 	4 $ 	— $ 	1 $ 	4 $ 	6
Interest cost 	7 	8 	4 	3 	14 	7
Expected return on plan assets 	(6) 	(6) 	(4) 	(3) 	(16) 	(15)
Recognized net actuarial losses (gains) 	2 	1 	(1) 	— 	3 	1
Amortization of prior service cost (credit) 	— 	— 	— 	(1) 	1 	—
Net periodic benefit costs (credits) 	5 	7 	(1) 	— 	6 	(1)
Settlement losses 	— 	16 	— 	— 	— 	1
Total, including other postretirement losses (gains) $ 	5 $ 	23 $ 	(1) $ 	— $ 	6 $ 	—
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Nine Months Ended September 30, 	2023 	2022 	2023 	2022 	2023 	2022
Service cost 	$ 	6 $ 	12 $ 	1 $ 	2 $ 	12 $ 	19
Interest cost 	21 	20 	11 	8 	43 	26
Expected return on plan assets 	(17) 	(22) 	(13) 	(9) 	(48) 	(50)
Recognized net actuarial losses (gains) 	5 	2 	(4) 	— 	9 	1
Amortization of prior service cost (credit) 	— 	— 	— 	(1) 	1 	—
Net periodic benefit costs (credits) 	15 	12 	(5) 	— 	17 	(4)
Settlement losses 	1 	29 	— 	— 	1 	10
Total, including other postretirement losses (gains) $ 	16 $ 	41 $ 	(5) $ 	— $ 	18 $ 	6
6. Debt and lines of credit
Short-term borrowings
We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As
of September 30, 2023, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade
banks that allows us to borrow up to $1 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed
to the applicable Term Secured Overnight Financing Rate (Term SOFR). As of September 30, 2023, our credit facility was undrawn, and we
had no commercial paper outstanding.
Long-term debt
In May 2023, we issued three series of senior unsecured notes for an aggregate principal amount of $1.60 billion, consisting of:
• $200 million further issuance of existing 4.60% notes due in 2028;
• $200 million further issuance of existing 4.90% notes due in 2033; and
• $1.20 billion of 5.05% notes due in 2063.
We incurred $7 million of issuance cost and other related costs. The proceeds of the offering were $1.60 billion, net of the original issuance
discounts and premiums, which will be used for general corporate purposes.
In May 2023, we retired $500 million of maturing debt.
13

-- 13 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
In March 2023, we issued two series of senior unsecured notes for an aggregate principal amount of $1.40 billion, consisting of $750 million
of 4.90% notes due in 2033 and $650 million of 5.00% notes due in 2053. We incurred $11 million of issuance and other related costs. The
proceeds of the offering were $1.40 billion, net of the original issuance discounts, which will be used for general corporate purposes.
Long-term debt outstanding is as follows:
September 30, 	December 31,
2023 	2022
Notes due 2023 at 2.25% 	$ 	— $ 	500
Notes due 2024 at 2.625% 	300 	300
Notes due 2024 at 4.70% 	300 	300
Notes due 2025 at 1.375% 	750 	750
Notes due 2026 at 1.125% 	500 	500
Notes due 2027 at 2.90% 	500 	500
Notes due 2028 at 4.60% 	700 	500
Notes due 2029 at 2.25% 	750 	750
Notes due 2030 at 1.75% 	750 	750
Notes due 2031 at 1.90% 	500 	500
Notes due 2032 at 3.65% 	400 	400
Notes due 2033 at 4.90% 	950 	—
Notes due 2039 at 3.875% 	750 	750
Notes due 2048 at 4.15% 	1,500 	1,500
Notes due 2051 at 2.70% 	500 	500
Notes due 2052 at 4.10% 	300 	300
Notes due 2053 at 5.00% 	650 	—
Notes due 2063 at 5.05% 	1,200 	—
Total debt 	11,300 	8,800
Net unamortized discounts, premiums and issuance costs 	(78) 	(65)
Total debt, including net unamortized discounts, premiums and issuance costs 	11,222 	8,735
Current portion of long-term debt 	(300) 	(500)
Long-term debt 	$ 	10,922 $ 	8,235
Interest and debt expense was $98 million and $53 million for the third quarters of 2023 and 2022, respectively, and $255 million and $154
million for the first nine months of 2023 and 2022, respectively. This was net of the amortized discounts, premiums, issuance and other
related costs. Capitalized interest was not material.
14

-- 14 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
7. Stockholders’ equity
Changes in equity are as follows:
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2022 	$ 	1,741 $ 	2,951 $ 	50,353 $ 	(40,214) $ 	(254)
2023
Net income 	— 	— 	1,708 	— 	—
Dividends declared and paid ($1.24 per share) 	— 	— 	(1,125) 	— 	—
Common stock issued for stock-based awards 	— 	(37) 	— 	118 	—
Stock repurchases 	— 	— 	— 	(96) 	—
Stock compensation 	— 	104 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	2
Dividend equivalents on RSUs 	— 	— 	(6) 	— 	—
Other 	— 	(2) 	— 	— 	—
Balance, March 31, 2023 	1,741 	3,016 	50,930 	(40,192) 	(252)
Net income 	— 	— 	1,722 	— 	—
Dividends declared and paid ($1.24 per share) 	— 	— 	(1,125) 	— 	—
Common stock issued for stock-based awards 	— 	36 	— 	29 	—
Stock repurchases 	— 	— 	— 	(77) 	—
Stock compensation 	— 	111 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	6
Dividend equivalents on RSUs 	— 	— 	(5) 	— 	—
Balance, June 30, 2023 	1,741 	3,163 	51,522 	(40,240) 	(246)
Net income 	— 	— 	1,709 	— 	—
Dividends declared and paid ($1.24 per share) 	— 	— 	(1,126) 	— 	—
Common stock issued for stock-based awards 	— 	38 	— 	35 	—
Stock repurchases 	— 	— 	— 	(48) 	—
Stock compensation 	— 	79 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	11
Dividend equivalents on RSUs 	— 	— 	(6) 	— 	—
Other 	— 	— 	(1) 	— 	—
Balance, September 30, 2023 	$ 	1,741 $ 	3,280 $ 	52,098 $ 	(40,253) $ 	(235)
15

-- 15 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2021 	$ 	1,741 $ 	2,630 $ 	45,919 $ 	(36,800) $ 	(157)
2022
Net income 	— 	— 	2,201 	— 	—
Dividends declared and paid ($1.15 per share) 	— 	— 	(1,063) 	— 	—
Common stock issued for stock-based awards 	— 	(36) 	— 	93 	—
Stock repurchases 	— 	— 	— 	(584) 	—
Stock compensation 	— 	74 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	4
Dividend equivalents on RSUs 	— 	— 	(5) 	— 	—
Other 	— 	(1) 	1 	— 	—
Balance, March 31, 2022 	1,741 	2,667 	47,053 	(37,291) 	(153)
Net income 	— 	— 	2,291 	— 	—
Dividends declared and paid ($1.15 per share) 	— 	— 	(1,060) 	— 	—
Common stock issued for stock-based awards 	— 	31 	— 	25 	—
Stock repurchases 	— 	— 	— 	(1,266) 	—
Stock compensation 	— 	85 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	(27)
Dividend equivalents on RSUs 	— 	— 	(4) 	— 	—
Balance, June 30, 2022 	1,741 	2,783 	48,280 	(38,532) 	(180)
Net income 	— 	— 	2,295 	— 	—
Dividends declared and paid ($1.15 per share) 	— 	— 	(1,051) 	— 	—
Common stock issued for stock-based awards 	— 	26 	— 	52 	—
Stock repurchases 	— 	— 	— 	(996) 	—
Stock compensation 	— 	68 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	26
Dividend equivalents on RSUs 	— 	— 	(5) 	— 	—
Balance, September 30, 2022 	$ 	1,741 $ 	2,877 $ 	49,519 $ 	(39,476) $ 	(154)
8. Contingencies
Indemnification guarantees
We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal,
infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.
Warranty costs/product liabilities
Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the
buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on
product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse
effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably
estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability.
16

-- 16 of 33 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
General
We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we
believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements.
9. Supplemental financial information
Restructuring charges/other
During the third quarter and first nine months of 2022, restructuring charges/other included $77 million and $209 million, respectively, of
preproduction costs at our Lehi, Utah, manufacturing facility, which were included in Other for segment reporting purposes. These costs
transitioned primarily to cost of revenue after production began in December 2022.
Other long-term assets
September 30, 	December 31,
2023 	2022
U.S. CHIPS and Science Act investment tax credit 	$ 	1,153 $ 	395
Other 	770 	740
Total 	$ 	1,923 $ 	1,135
Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income
Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the third quarters
and first nine months of 2023 and 2022. The table below details where these transactions are recorded in our Consolidated Statements of
Income.
For Three Months Ended 	For Nine Months Ended
Impact to Related Statement of
Income Lines
September 30, 	September 30,
2023 	2022 	2023 	2022
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement
losses (a) 	$ 	4 $ 	19 $ 	12 $ 	42 Decrease to OI&E
Tax effect 	(1) 	(4) 	(3) 	(9)
Decrease to provision for
income taxes
Recognized within net income, net of taxes 	$ 	3 $ 	15 $ 	9 $ 	33 Decrease to net income
Prior service cost (credit) of defined benefit
plans:
Amortization of prior service cost (credit) (a) $ 	1 $ 	(1) $ 	1 $ 	(1) Decrease (increase) to OI&E
Tax effect 	— 	— 	— 	—
(Decrease) increase to
provision for income taxes
Recognized within net income, net of taxes 	$ 	1 $ 	(1) $ 	1 $ 	(1) Decrease (increase) to net
income
(a) Detailed in Note 5
Stock compensation
During the first nine months of 2023, 3 million shares were issued from treasury related to stock compensation. Shares issued from treasury
during the third quarter of 2023 were less than 1 million.
17

-- 17 of 33 --

ITEM 2. Management’s discussion and analysis of financial condition and results of operations
Overview
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. Technology is the
foundation of our company, but ultimately, our objective and the best metric for owners to measure our progress is through the growth of free
cash flow per share over the long term.
Our strategy to maximize long-term free cash flow per share growth has three elements:
1. A great business model that is focused on analog and embedded processing products and built around four sustainable competitive
advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:
i. A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.
ii. A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for
our investments.
iii. The reach of our market channels that gives access to more customers and more of their design projects, leading to the
opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.
iv. Diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer
returns on our investments.
Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning
significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of
these advantages.
2. Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities like
TI.com, invest in new manufacturing capacity or how we think about acquisitions and returning cash to our owners.
3. Efficiency, which means constantly striving for more output for every dollar spent.
We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a
long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit
of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to
generate value.
Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the
financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:
• Our segments represent groups of similar products that are combined on the basis of similar design and development requirements,
product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures
results. See Note 1 to the financial statements for more information regarding our segments.
• When we discuss our results:
◦ Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by
fluctuations in shipment volumes.
◦ New products do not tend to have a significant impact on our revenue in any given period because we sell such a large
number of products.
◦ From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced
products, which we refer to as changes in the “mix” of products shipped.
18

-- 18 of 33 --

◦ Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory
loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins
decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other
circumstances, our profit margins increase.
• For an explanation of free cash flow, see the Non-GAAP financial information section.
• All dollar amounts in the tables are stated in millions of U.S. dollars.
Performance summary
Our third quarter revenue was $4.53 billion, net income was $1.71 billion and earnings per share (EPS) were $1.85.
Revenue was flat sequentially and decreased 14% from the same quarter a year ago. During the quarter, automotive growth continued and
industrial weakness broadened.
Our cash flow from operations of $6.5 billion for the trailing 12 months again underscored the strength of our business model, the quality of
our product portfolio and the benefit of 300-mm production. Free cash flow for the same period was $1.6 billion and 9% of revenue.
Over the past 12 months we invested $3.7 billion in R&D and SG&A, invested $4.9 billion in capital expenditures and returned $5.6 billion to
shareholders.
Results of operations – third quarter 2023 compared with third quarter 2022
Revenue of $4.53 billion decreased $709 million, or 14%, primarily due to lower revenue from Analog, partially offset by higher revenue from
Embedded Processing.
Gross profit of $2.82 billion was down $802 million, or 22%, primarily due to lower revenue and, to a lesser extent, higher manufacturing
costs associated with planned capacity expansion and reduced factory loadings. As a percentage of revenue, gross profit decreased to
62.1% from 69.0%.
Operating expenses (R&D and SG&A) were $923 million compared with $862 million. This increase was due to higher employee-related
costs as we invest to strengthen our competitive advantages.
Restructuring charges/other in the year-ago period was $77 million due to preproduction costs at our Lehi, Utah, manufacturing facility. These
costs transitioned primarily to cost of revenue after production began in December 2022.
Operating profit was $1.89 billion, or 41.7% of revenue, compared with $2.68 billion, or 51.1% of revenue.
OI&E was $128 million of income compared with $33 million of income, primarily due to higher interest income.
Interest and debt expense of $98 million increased $45 million due to the issuance of additional long-term debt. See Note 6 to the financial
statements.
Our provision for income taxes was $213 million compared with $363 million. This decrease was primarily due to lower income before income
taxes.
Net income was $1.71 billion compared with $2.30 billion. EPS was $1.85 compared with $2.47.
19

-- 19 of 33 --

Third quarter 2023 segment results
Our segment results compared with the year-ago quarter are as follows:
Analog (includes Power and Signal Chain product lines)
Q3 2023 	Q3 2022 	Change
Revenue 	$ 	3,353 	$ 	3,993 	(16)%
Operating profit 	1,504 	2,185 	(31)%
Operating profit % of revenue 	44.9 % 	54.7 %
Analog revenue decreased in both product lines at about the same rate. Operating profit decreased primarily due to lower revenue and
higher manufacturing costs.
Embedded Processing (includes microcontrollers and processors)
Q3 2023 	Q3 2022 	Change
Revenue 	$ 	890 	$ 	821 	8 %
Operating profit 	258 	321 	(20)%
Operating profit % of revenue 	29.0 % 	39.1 %
Embedded Processing revenue increased due to the mix of products shipped. Operating profit decreased primarily due to higher
manufacturing costs, partially offset by higher revenue.
Other (includes DLP products, calculators and custom ASIC products)
Q3 2023 	Q3 2022 	Change
Revenue 	$ 	289 	$ 	427 	(32)%
Operating profit* 	130 	172 	(24)%
Operating profit % of revenue 	45.0 % 	40.3 %
* Includes restructuring charges/other
Other revenue decreased $138 million, and operating profit decreased $42 million.
Results of operations – first nine months of 2023 compared with first nine months of 2022
Revenue of $13.44 billion decreased $1.92 billion, or 12%, primarily due to lower revenue from Analog, partially offset by higher revenue
from Embedded Processing.
Gross profit of $8.59 billion was down $2.10 billion, or 20%, due to lower revenue and, to a lesser extent, higher manufacturing costs
associated with planned capacity expansion and reduced factory loadings. As a percentage of revenue, gross profit decreased to 63.9% from
69.6%.
Operating expenses were $2.79 billion compared with $2.51 billion. This increase was due to higher employee-related costs as we invest to
strengthen our competitive advantages.
Restructuring charges/other in the year-ago period was $209 million due to preproduction costs at our Lehi, Utah, manufacturing facility.
These costs transitioned primarily to cost of revenue after production began in December 2022.
Operating profit was $5.80 billion, or 43.1% of revenue, compared with $7.96 billion, or 51.9% of revenue.
OI&E was $327 million of income compared with $55 million of income, due to higher interest income.
Interest and debt expense of $255 million increased $101 million due to the issuance of additional long-term debt.
®
20

-- 20 of 33 --

Our provision for income taxes was $731 million compared with $1.08 billion. This decrease was due to lower income before income taxes.
Net income was $5.14 billion compared with $6.79 billion. EPS was $5.58 compared with $7.27.
Year-to-date segment results
Our segment results compared with the year-ago period are as follows:
Analog
YTD 2023 	YTD 2022 	Change
Revenue 	$ 	9,920 	$ 	11,801 	(16)%
Operating profit 	4,541 	6,561 	(31)%
Operating profit % of revenue 	45.8 % 	55.6 %
Analog revenue decreased in both product lines, led by Power. Operating profit decreased primarily due to lower revenue and higher
manufacturing costs.
Embedded Processing
YTD 2023 	YTD 2022 	Change
Revenue 	$ 	2,616 	$ 	2,424 	8 %
Operating profit 	813 	960 	(15)%
Operating profit % of revenue 	31.1 % 	39.6 %
Embedded Processing revenue increased due to the mix of products shipped. Operating profit decreased primarily due to higher
manufacturing costs, partially offset by higher revenue.
Other
YTD 2023 	YTD 2022 	Change
Revenue 	$ 	906 	$ 	1,133 	(20)%
Operating profit* 	444 	443 	— %
Operating profit % of revenue 	49.0 % 	39.1 %
* Includes restructuring charges/other
Other revenue decreased $227 million, and operating profit increased $1 million.
Financial condition
At the end of the third quarter of 2023, total cash (cash and cash equivalents plus short-term investments) was $8.95 billion, a decrease of
$119 million from the end of 2022.
Accounts receivable were $1.98 billion, an increase of $81 million compared with the end of 2022. Days sales outstanding for the third
quarter of 2023 were 39 compared with 37 at the end of 2022.
Inventory was $3.91 billion, an increase of $1.15 billion from the end of 2022. Days of inventory for the third quarter of 2023 were 205
compared with 157 at the end of 2022.
21

-- 21 of 33 --

Liquidity and capital resources
Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term
investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of September 30, 2023, our credit facility
was undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first nine months of 2023 were
$4.50 billion, a decrease of $2.18 billion from the year-ago period due to lower net income and higher cash used for working capital, as we
continued to strategically build inventory.
Investing activities for the first nine months of 2023 used $4.05 billion compared with $2.56 billion in the year-ago period. Capital
expenditures were $3.92 billion compared with $1.83 billion in the year-ago period and were primarily for semiconductor manufacturing
equipment and facilities in both periods. Short-term investments used cash of $164 million compared with $788 million in the year-ago period.
As we continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity
planning, our capital expenditures are expected to be higher than historical levels. In August 2022, the U.S. government enacted the U.S.
CHIPS and Science Act, which provides funding for manufacturing grants and research investments and establishes a 25% investment tax
credit for certain investments in U.S. semiconductor manufacturing. We expect to receive the cash benefit associated with the investment tax
credit for qualifying capital expenditures in future periods. See Note 9 to the financial statements.
Financing activities for the first nine months of 2023 used $929 million compared with $5.58 billion in the year-ago period. In 2023, we
received net proceeds of $3.00 billion from the issuance of fixed-rate, long-term debt, and we retired maturing debt of $500 million. In the
year-ago period, we received net proceeds of $695 million from the issuance of fixed-rate, long-term debt, and we retired maturing debt of
$500 million. Dividends paid were $3.38 billion compared with $3.17 billion in the year-ago period, reflecting an increased dividend rate,
partially offset by fewer shares outstanding. We used $228 million to repurchase 1.3 million shares of our common stock compared with
$2.77 billion used in the year-ago period to repurchase 16.8 million shares. Employee exercises of stock options provided cash proceeds of
$218 million compared with $191 million in the year-ago period.
In September 2023, we announced we would increase our dividend by 5%, marking 20 consecutive years of dividend increases.
We had $2.57 billion of cash and cash equivalents and $6.38 billion of short-term investments as of September 30, 2023. We believe we
have the necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-
related payments, and other business requirements for at least the next 12 months.
22

-- 22 of 33 --

Non-GAAP financial information
This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in
accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow was calculated by subtracting capital
expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from
operations).
We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of
cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are
supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measures is provided in the table below.
For 12 Months Ended
September 30,
2023 	2022 	Change
Cash flow from operations (GAAP) 	$ 	6,538 	$ 	9,035 	(28)%
Capital expenditures 	(4,890) 	(3,112)
Free cash flow (non-GAAP) 	$ 	1,648 	$ 	5,923 	(72)%
Revenue 	$ 	18,112 	$ 	20,190
Cash flow from operations as a percentage of revenue (GAAP) 	36.1 % 	44.7 %
Free cash flow as a percentage of revenue (non-GAAP) 	9.1 % 	29.3 %
23

-- 23 of 33 --

ITEM 4. Controls and procedures
An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of
management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon
that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were
effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)
under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, our internal control over financial reporting.
24

-- 24 of 33 --

PART II – OTHER INFORMATION
ITEM 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2022, and is incorporated
by reference herein.
ITEM 2. Unregistered sales of equity securities and use of proceeds
The following table contains information regarding our purchases of our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
Period Total Number of Shares
Purchased
Average Price
Paid per Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs (a)
Approximate Dollar Value
of Shares that May Yet Be
Purchased Under the Plans
or Programs (a)
July 1, 2023 through July 31, 2023 	61,656 	$ 177.82 	50,020 	$ 21.30 billion
August 1, 2023 through August 31, 2023 	109,035 	168.59 	109,035 	21.28 billion
September 1, 2023 through September 30, 2023 	126,201 	162.42 	126,201 	21.26 billion
Total 	296,892 (b) 	$ 167.89 (b) 	285,256 	$ 21.26 billion (c)
(a) All open-market purchases during the quarter were made under the authorizations from our board of directors to purchase up to $12.0
billion and $15.0 billion of additional shares of TI common stock announced September 20, 2018, and September 15, 2022, respectively.
(b) In addition to open-market purchases, 11,636 shares of common stock were surrendered by employees to satisfy tax withholding
obligations in connection with the vesting of restricted stock units.
(c) As of September 30, 2023, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018 and the
$15.0 billion authorized in September 2022. No expiration date has been specified for these authorizations.
25

-- 25 of 33 --

ITEM 6. Exhibits
Designation of Exhibits in
This Report 	Description of Exhibit
3(a) Restated Certificate of Incorporation of the Registrant, dated April 18, 1985, as amended (incorporated by reference
to Exhibit 3(a) of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014).
3(b) By-Laws of the Registrant (incorporated by reference to Exhibit 3 of the Registrant’s Current Report on Form 8-K
filed January 26, 2022).
31(a) 	Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
31(b) 	Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
32(a) 	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
32(b) 	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
101.ins XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.†
101.def 	XBRL Taxonomy Extension Definition Linkbase Document.†
101.sch 	XBRL Taxonomy Extension Schema Document.†
101.cal 	XBRL Taxonomy Extension Calculation Linkbase Document.†
101.lab 	XBRL Taxonomy Extension Label Linkbase Document.†
101.pre 	XBRL Taxonomy Extension Presentation Linkbase Document.†
104 	Cover Page Interactive Data File (embedded within the Inline XBRL document).†
† Filed or furnished herewith.
26

-- 26 of 33 --

Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management
“believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements
herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in
forward-looking statements.
We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI
or our management:
• Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate,
including global trade policies;
• Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from
forecasts;
• Our ability to compete in products and prices in an intensely competitive industry;
• Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and
other third parties;
• Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to
realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
• Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely
implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected
returns on significant investments in manufacturing capacity;
• The duration and scope of the COVID-19 pandemic, government and other third-party responses to it and the consequences for the
global economy, including to our business and the businesses of our suppliers, customers and distributors;
• Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing
technology;
• Our ability to recruit and retain skilled personnel, and effectively manage key employee succession;
• Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or
communications, or recalls by our customers for a product containing one of our parts;
• Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of
enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
• Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are
determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax
assets;
• Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or
disputes with current or former distributors;
• Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
• Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover
our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
• Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where
we conduct business; or our exposure to infringement claims;
• Instability in the global credit and financial markets; and
27

-- 27 of 33 --

• Impairments of our non-financial assets.
For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-
looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-
looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that
we will make additional updates with respect to that statement or any other forward-looking statement.
28

-- 28 of 33 --

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
TEXAS INSTRUMENTS INCORPORATED
By: 	/s/ Rafael R. Lizardi
Rafael R. Lizardi, Senior Vice President and Chief
Financial Officer
Date: October 25, 2023

-- 29 of 33 --

Exhibit 31(a)
CERTIFICATIONS
I, Haviv Ilan, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.
Date: October 25, 2023
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 30 of 33 --

Exhibit 31(b)
CERTIFICATIONS
I, Rafael R. Lizardi, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.
Date: October 25, 2023
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 31 of 33 --

Exhibit 32(a)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Haviv Ilan,
President and Chief Executive Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2023, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 25, 2023
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 32 of 33 --

Exhibit 32(b)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Rafael R. Lizardi,
Senior Vice President and Chief Financial Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2023, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 25, 2023
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 33 of 33 --